NOVEL TRI-SUBSTITUTED AMINE, ITS PRODUCTION AND TREATMENT AGENT OF HEART AND CIRCULATORY ORGAN DISEASE CONTAINING SAID AMINE

Compounds of the formula I in which R1 denotes hydrogen, an alkyl or alkenyl radical, a cycloalkyl or cycloalkenyl radical or an optionally substituted monocyclic aromatic or heteroaromatic radical, R2 and R3 denote an alkyl radical or together denote a ring, R4 denotes an optionally substituted monocyclic aromatic or heteroaromatic radical, R5 denotes hydrogen, nitrile, carboxylic acid ester or an optionally substituted monocyclic aromatic or heteroaromatic radical, R6 denotes hydrogen, nitrile, carboxylic acid, carboxylic acid ester, carboxylic acid amide or hydroxymethyl, X denotes a valence line or the methylene group, Y denotes a valence line or an optionally substituted alkyl or alkenyl radical, and Z denotes a valence line, an oxygen atom or the carbonyl group, and their pharmacologically tolerable salts and optical isomers, process for their preparation and pharmaceutical preparations containing these compounds for the treatment of cardiac and circulatory disorders.